Barclays »

Dermata Therapeutics shares owned by Barclays

Quarter-by-quarter ownership of Dermata Therapeutics (DRMA) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Dermata Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Dermata Therapeutics held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Dermata Therapeutics by Barclays

Quarter filed Position value Share count Share price at filing
2025-12-31 $5.6k 2.4k 2.32

More positions owned by Barclays

SPDR S&ampP 500 ETF TR Fund (SPY)
Invesco Qqq Tr Fund (QQQ)
NVIDIA Corporation (NVDA)
Microsoft Corp Opt Put Option (MSFT)
Apple (AAPL)
Ishares Tr Opt Call Option (IWM)
Alphabet Inc Class A cs (GOOGL)
Amazon (AMZN)
Tesla Motors (TSLA)
Facebook Inc cl a (META)
Broadcom (AVGO)
Alphabet Inc Class C cs (GOOG)
Ishares Tr Opt Put Option (HYG)
Advanced Micro Devices (AMD)
JPMORGAN CHASE &amp Opt Put Option (JPM)

View all positions for Barclays

Top funds holding Dermata Therapeutics

Armistice Capital
Barclays
Tower Research Capital
UBS Group
SBI Securities

View all funds holding Dermata Therapeutics